Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GDUFA IV: More ANDA Postmarket Commitments Coming?
Feb 18 2026
•
By
Derrick Gingery
Would more generic drug PMRs and PMCs create resource issues for the FDA?
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from United States